相关实验视频

Updated: Jun 30, 2025

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

[¹⁸F]FET PET/MRI:用于检测小功能性垂体瘤的准确技术

Ilanah J Pruis¹, Frederik A Verburg¹, Rutger K Balvers²

¹Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

|March 21, 2024

概括

新的[18F]FET PET/MRI有效检测小功能性垂体瘤,改善诊断和治疗库辛病患者的不确的MRI结果. 这种先进的成像提供了比传统方法更高的准确性.

科学领域:

核医学是一种核医学.
放射学放射学是一门学科.
内分泌学在内分泌学.

背景情况:

小型功能性垂体瘤会引起严重的症状,难以诊断.
目前的诊断标准,如MRI和IPSS有局限性,留下高达40%的患者不确定瘤来源.
这种诊断不确定性阻止了及时的手术或放射治疗,影响了治愈率.

研究的目的:

评估O-(2-[18F]甲基) -l-氨酸 ([18F]FET) PET/MRI在识别小功能性垂体瘤的诊断性能.
评估[18F]FET PET/MRI在患有库辛病且之前有不确定的MRI结果的患者中的实用性.
为了比较[18F]FET PET/MRI的诊断产量与传统的MRI和下层状鼻采样 (IPSS).

主要方法:

对患有库辛病的患者和接受[18F]FET PET/MRI的阴性/不确定的MRI患者的回顾性分析.
经验丰富的放射科医生单独对PET/MRI和MRI进行评估.
将成像结果与术后组织分析,先前的MRI,IPSS和临床随访结果进行比较.

主要成果:

[18F]FET PET/MRI在所有患者中发现了代谢焦点,而单独的MRI仅在50%的患者中显示了可疑的病变.
通过[18F]FET PET/MRI指导的手术证实了10/15例 (73% PPV) 患者的垂体腺瘤和1/15例的垂体细胞瘤,达到100%的灵敏度.
与IPSS相比,[18F]FET PET/MRI的侧面化准确性得到改善,75%的治疗患者实现了短期缓解.

结论:

[18F]FET PET/MRI在定位小功能性垂体瘤方面表现出高的诊断准确性.
这种多式成像技术显著改善了库辛病患者的诊断和手术规划.
[18F]FET PET/MRI的改善诊断能力导致更好的临床结果,特别是在具有挑战性的病例中,先前的成像无法确定.

关键词:

库辛病是什么病?库辛病是什么病?有关PET/MRI的研究.[18F]FET可以使用.pituitary 瘤 pituitary 瘤瘤瘤瘤瘤瘤

更多相关视频

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...